Lucy Scientific Discovery Inc. - Common Stock (LSDI)

$0.48 0.09 (16.16%)

15:54 EDT LSDI Stock Quote Delayed 30 Minutes

LSDI Stock Alert: Lucy Scientific Soars on Product Launch Update

By Larry Ramer, InvestorPlace Contributor May 19, 2023

Lucy Scientific Discovery announced that it would partner with Canadian nonprofit TheraPsil. This has sent LSDI stock rallying 30%.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 208,058

Day's Range $0.47 - $0.59

52-Week Range $0.47 - $4.00

Dividend & Yield N/A (N/A)

LSDI Stock Predictions, Articles, and Lucy Scientific Discovery Inc. - Common Stock News

From the Web

Lucy Scientific rises after BlueSky Wellness acquisition announcement (NASDAQ:LSDI)

From Seeking Alpha Sep 12, 2023

Lucy Scientific Discovery (LSDI) rose ~11% Tuesday pre-market after the psychedelic products company said it is set to acquire BlueSky Wellness.The company has entered into an agreement...

Lucy Scientific acquires High Times intellectual property (NASDAQ:LSDI)

From Seeking Alpha Sep 7, 2023

Lucy Scientific Discovery (LSDI) said on Thursday that it had acquired the intellectual property of High Times.Shares of LSDI rose 1.8%. According to LSDI, the acquisition will provide...

Lucy Scientific Discovery names Nanula new CEO, McElvany steps down (NASDAQ:LSDI)

From Seeking Alpha Jul 13, 2023

Lucy Scientific Discovery (LSDI) has named executive chairman Richard Nanula as its new chief executive officer, succeeding Chris McElvany, the company said Thursday

Best and worst performing healthcare IPOs of 2023, so far (NASDAQ:GNLX)

From Seeking Alpha Jul 4, 2023

Genelux, Structure Therapeutics and Jin Medical have been the best performing healthcare IPOs so far this year, with interest in new listings finally picking up. Read more here.

Lucy Scientific makes bid to buy Pasithea for $0.85 in cash and stock (NASDAQ:LSDI)

From Seeking Alpha Jun 5, 2023

Lucy Scientific Discovery (LSDI), a producer of medicinal psychedelic compounds, has made a bid to acquire Pasithea Therapeutics (KTTA) for $0.85 per share in cash and stock.

Psychotropic drugmaker Lucy Scientific stock drops 10% after $7.5M IPO

From Seeking Alpha Feb 9, 2023

Lucy Scientific Discovery (LSDI), a contract manufacturer of compounds for psychedelic and psychotropic therapies, saw its shares slide 10% following a $7.5M IPO. Read more here.